CRM Software White Papers

Pharmaceutical Client Seeks Assistance in Prioritizing Its Nanotechnology R&D Strategy

Overview After surveying the shifting pharmaceutical technology landscape, the multinational pharmaceutical company sought a strategy and roadmap to help guide its future development efforts. In response, IBM proposed a two-part process. First, IBM Research, working together with GBS, leveraged IBM's existing nanotechnology research and extensive in-house expertise to provide a framework to guide the process. The GBS Strategy and Change team then used IBM's Business Insights Workbench (BIW) tool, VentureSource, and a host of other third party research to search for existing pharmaceutical nanotechnology-related patents, VC funding, global government and academic funding, publications, and commercialized and pipeline drugs using nanotechnology.

Further White Paper Details
PublisherIBM File FormatHTML
Date PublishedJanuary 2008
FormatCase Studies   
Topics

Quick Sitemap Links: